.
BioEnterprise

Parker Hannifin Receives FDA Clearance to Sell Indego Device in U.S. for Clinical, Personal Use

Parker Hannifin Corp. receives clearance from the U.S. Food and Drug Administration to market and sell the Indego exoskeleton for clinical and personal use in the United States.

Read More  >